3Clopidogrel in Unstable Angina to Prevent Recurrent Events Investigators.Effects of clopidofrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation[J].N Engl J Med,2001,245:494-502.
4陈纪林.抗血板治疗的规范化问题.长城心脏快讯,2005,2:2-2.
5Michael A,James A,Harvey D,et al.Safety and efficacy of enoxaparin unfractionated heparin in patients with non-st-segment elevateon acute coronary syndromes who receive tirofiban and aspirin a randomized controlled trial[J].JAMA,2004,292:55-64.
6Wong,GC,Giμgliano RP,Antman EM.Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention[J].JAMA,2003,289:331-342.
7Schwartz GG,Olsson AG,Ezekowitz MD,et al.Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes:the MIRACL study:a randomized controlled trial[J].JAMA,2001,285:1711-1718.
8Cannon CP,Braunwald E,Mccabe CH,et al.Intensive versus moderate lipid lowering with Statins after acute coronary syndromes[J].N Engl J Med,2004,350:1495-1504.
9Davices MJ,Peter T,Clake ED.Reduction of enzyme levels by proprdnolol after acute myocardial infarction[J].Circulation,1984,310:1130-1137.
10Wallentin L,Lagervist B,Husted S,et al.Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronrey artery disease:the FRISC Ⅱ invasive randomized trial[J].Lancet,2000,356:9-16.
二级参考文献56
1[1]Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines( Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol, 2002,40:1366-1374.
2[2]Natarajan M. Unstable angina. Clin Evi, 2002,7:214-226.
3[3]Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST segment elevation: the Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J,2002,23:1809 - 1840.
4[4]Solymoss BC, et al. Classification and risk stratification of patients with acute chest pain using a low discriminatory level of cardiac troponin T. Clin Cardiol, 2004,27:130-136.
5[5]Sabatine MS, McCabe CH, Morrow DA, et al. Identification of patients at high risk for death and cardiac ischemic events after hospital discharge. Am Heart J, 2002,143:966-970.
6[6]Koukkunen H, K Pyorala and O H M. Low-risk patients with chest pain and without evidence of myocardial infarction may be safely discharged from emergency department. Eur Heart J, 2004,25:329-334.
7[7]Wallentin L, Lagervist B, Husted S, et al. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary artery disease: the FRISC Ⅱ invasive randomized trial. Lancet,2000,356:9-16.
8[8]Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary artery syndromes without ST-segment elevation. N Engl J Med, 2001,345:494-502.
9[9]Clopidogrel in Unstable Angina to Prevent Recurrent Events Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001,345:494-502.
10[10]Mahta SR, Yusuf S, Peters RJ, et al. for the CURE Investigators.Effects of pretreatment with clopidogrel and aspirin followed by longterm therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet, 2001,358:527-533.
